Short-Course Radiotherapy Preserves Physical Function in Pancreatic Cancer

Short-Course Radiotherapy Preserves Physical Function in Pancreatic Cancer

Findings from a phase II randomized clinical trial, presented at the American Society for Radiation Oncology (ASTRO) annual meeting in Boston, indicate that patients with pancreatic cancer awaiting surgery derive significant benefits from a short-course stereotactic radiotherapy regimen.

The “SOFT Preop” trial compared two preoperative treatment protocols: stereotactic body radiotherapy (SBRT) delivered over five sessions, and traditional chemoradiotherapy spanning 28 sessions. Both groups had previously undergone induction chemotherapy.

The study cohort included patients with pancreatic adenocarcinoma, encompassing those with resectable, borderline resectable, and locally advanced disease. Participants were randomized to evaluate differences in health outcomes and quality of life.

Regarding the study’s primary endpoint—the presence of cancer cells in lymph nodes following treatment but prior to surgical intervention—the results showed no statistically significant difference between the two regimens. This suggests that the longer, traditional treatment protocol does not offer superior medical efficacy in this specific metric compared to the short-course system.

However, patient-reported outcomes favored the short-course stereotactic radiotherapy. This approach was associated with better preservation of the patients’ physical function and lower levels of fatigue. These markers are critical for patients preparing for major surgery, as reducing the treatment burden contributes to improved physical and psychological readiness for the procedure.

These results align with recent scientific trends aimed at developing more precise and time-efficient treatment protocols for cancer patients. Such efforts strive to balance the therapeutic efficacy required to eliminate malignant cells with the reduction of side effects and the taxing burdens imposed by extended treatment periods, ultimately enhancing the quality of life for patients both before and after surgical intervention.


Source: Syria Focus Arabic